Ikarian Capital, LLC
- SEC CIK
- 0001778253
- 最新申報
- 2026/8/14
2026 年第 1 季持倉
持倉截至 2026/3/31，2026/5/15 申報。只含多頭部位，變化是跟 2025 年第 4 季比股數。
- 持股檔數
- 127
- 較 2025 年第 4 季 −8
- 總值
- $6.99 億
- 較 2025 年第 4 季 −$7,355 萬 (−9.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| TERNTerns Pharmaceuticals, Inc. | COM | 1,456,378 | $7,678 萬 | 11.0% | −140,000−8.8% | 減碼 | 歷史 |
| KODKodiak Sciences Inc. | COM | 1,265,795 | $4,825 萬 | 6.9% | +546,008+75.9% | 加碼 | 歷史 |
| ALMSAlumis Inc. | COM | 1,213,548 | $2,673 萬 | 3.8% | +1,213,548 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 428,682 | $2,491 萬 | 3.6% | +50,000+13.2% | 加碼 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 71,581 | $2,306 萬 | 3.3% | −15,000−17.3% | 減碼 | 歷史 |
| HROWHarrow, Inc. | COM | 543,047 | $1,915 萬 | 2.7% | +359,700+196.2% | 加碼 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 2,688,359 | $1,871 萬 | 2.7% | −380,000−12.4% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 283,572 | $1,869 萬 | 2.7% | +110,900+64.2% | 加碼 | 歷史 |
| TENXTenax Therapeutics, Inc. | COM NEW | 1,017,600 | $1,627 萬 | 2.3% | +50,000+5.2% | 加碼 | 歷史 |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 528,015 | $1,605 萬 | 2.3% | −50,000−8.7% | 減碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 163,142 | $1,587 萬 | 2.3% | +25,000+18.1% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 461,247 | $1,463 萬 | 2.1% | +461,247 | 新進 | 歷史 |
| PHVSPharvaris N.V. | COM | 486,856 | $1,375 萬 | 2.0% | 00.0% | 不變 | 歷史 |
| CNTBConnect Biopharma Holdings Ltd | SHS | 5,388,486 | $1,312 萬 | 1.9% | +600,000+12.5% | 加碼 | 歷史 |
| DRUGBright Minds Biosciences Inc. | COM NEW | 166,647 | $1,216 萬 | 1.7% | +7,226+4.5% | 加碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 160,120 | $1,189 萬 | 1.7% | +160,120 | 新進 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 242,021 | $1,187 萬 | 1.7% | +242,021 | 新進 | 歷史 |
| ANROAlto Neuroscience, Inc. | COM SHS | 515,000 | $1,158 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 344,123 | $1,152 萬 | 1.6% | +275,300+400.0% | 加碼 | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 378,999 | $1,131 萬 | 1.6% | −265,681−41.2% | 減碼 | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 147,085 | $1,131 萬 | 1.6% | +147,085 | 新進 | 歷史 |
| CTNMContineum Therapeutics, Inc. | CL A | 807,874 | $1,055 萬 | 1.5% | +525,000+185.6% | 加碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 482,571 | $1,011 萬 | 1.4% | +469,900+3,708.5% | 加碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 127,038 | $953.9 萬 | 1.4% | −75,000−37.1% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 598,281 | $892.0 萬 | 1.3% | −160,373−21.1% | 減碼 | 歷史 |
| EPRXEupraxia Pharmaceuticals Inc. | COM | 1,214,741 | $879.5 萬 | 1.3% | +604,741+99.1% | 加碼 | 歷史 |
| DMRADamora Therapeutics, Inc. | COM NEW | 335,710 | $869.5 萬 | 1.2% | +50,000+17.5% | 加碼 | 歷史 |
| PVLAPalvella Therapeutics, Inc. | COM | 64,626 | $805.6 萬 | 1.2% | +64,626 | 新進 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 1,049,161 | $804.7 萬 | 1.2% | −326,311−23.7% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 200,000 | $804.6 萬 | 1.2% | +200,000 | 新進 | 歷史 |
| SPRBSpruce Biosciences, Inc. | COM NEW | 121,356 | $793.1 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| IVAInventiva S.A. | ADS | 1,429,101 | $784.3 萬 | 1.1% | +926,500+184.3% | 加碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM NEW | 512,349 | $719.9 萬 | 1.0% | +212,349+70.8% | 加碼 | 歷史 |
| OCGNOcugen, Inc. | COM | 3,962,972 | $717.3 萬 | 1.0% | +3,962,972 | 新進 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 1,193,492 | $710.1 萬 | 1.0% | +391,170+48.8% | 加碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 2,894,704 | $642.6 萬 | 0.9% | +2,647,146+1,069.3% | 加碼 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 57,635 | $623.3 萬 | 0.9% | −148,350−72.0% | 減碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 6,547 | $602.2 萬 | 0.9% | −7,268−52.6% | 減碼 | 歷史 |
| ACOGAlpha Cognition Inc. | COM NEW | 1,056,259 | $579.9 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| PTHSPelthos Therapeutics Inc. | COM SHS | 256,598 | $539.1 萬 | 0.8% | +840+0.3% | 加碼 | 歷史 |
| SRZNSurrozen, Inc. | COM NEW | 173,107 | $504.3 萬 | 0.7% | +107,319+163.1% | 加碼 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 157,537 | $486.9 萬 | 0.7% | +157,537 | 新進 | 歷史 |
| ALECAlector, Inc. | COM | 2,082,606 | $447.8 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 226,888 | $410.4 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 733,435 | $408.5 萬 | 0.6% | +188,881+34.7% | 加碼 | 歷史 |
| LPCNLipocine Inc. | COM NEW | 508,556 | $406.3 萬 | 0.6% | +309,014+154.9% | 加碼 | 歷史 |
| DCTHDelcath Systems, Inc. | COM NEW | 431,251 | $400.2 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ARVNArvinas, Inc. | COM | 358,257 | $379.8 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 675,000 | $373.3 萬 | 0.5% | +275,000+68.8% | 加碼 | 歷史 |
| CRDLCardiol Therapeutics Inc. | COM CL A | 2,725,000 | $367.9 萬 | 0.5% | +2,725,000 | 新進 | 歷史 |
| BHVNBiohaven Ltd. | COM | 412,481 | $349.0 萬 | 0.5% | +200,000+94.1% | 加碼 | 歷史 |
| IVVDInvivyd, Inc. | COM | 2,656,570 | $345.4 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| ANNXAnnexon, Inc. | COM | 580,244 | $321.5 萬 | 0.5% | +350,000+152.0% | 加碼 | 歷史 |
| FBRXForte Biosciences, Inc. | COM NEW | 118,972 | $308.1 萬 | 0.4% | −181,028−60.3% | 減碼 | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 513,011 | $294.5 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| FRNMFreenome, Inc. | CL A ORD SHS | 240,951 | $264.3 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 293,258 | $262.8 萬 | 0.4% | −282,454−49.1% | 減碼 | 歷史 |
| NXTCNextCure, Inc. | COM NEW | 238,303 | $250.7 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| NMRANeumora Therapeutics, Inc. | COM | 1,278,408 | $249.3 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 1,053,797 | $248.7 萬 | 0.4% | +799,485+314.4% | 加碼 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 900,000 | $242.1 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | COM NEW | 270,231 | $241.9 萬 | 0.3% | +50,000+22.7% | 加碼 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 1,492,229 | $241.7 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NUVLNuvalent, Inc. | COM | 23,594 | $241.7 萬 | 0.3% | −36,000−60.4% | 減碼 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 12,460 | $235.6 萬 | 0.3% | −147,907−92.2% | 減碼 | 歷史 |
| DBVTDBV Technologies S.A. | SPONSORED ADS | 525,000 | $219.9 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 31,166 | $218.6 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KLRSKalaris Therapeutics, Inc. | COM | 360,000 | $207.7 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| AVRAnteris Technologies Global Corp. | COM | 366,571 | $203.4 萬 | 0.3% | +366,571 | 新進 | 歷史 |
| SLDBSolid Biosciences Inc. | COM NEW | 264,409 | $190.4 萬 | 0.3% | +104,000+64.8% | 加碼 | 歷史 |
| IBIOiBio, Inc. | COM NEW | 957,062 | $181.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CPIXCumberland Pharmaceuticals Inc | COM | 553,153 | $179.8 萬 | 0.3% | −2,779−0.5% | 減碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 865,784 | $173.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Direxion Shs ETF Tr25461H853 | DAILY S&P BIOTEC | 105,822 | $172.5 萬 | 0.2% | +65,000+159.2% | 加碼 | – |
| QUREuniQure N.V. | SHS | 91,060 | $148.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| QNRXQuoin Pharmaceuticals Ltd. | ADR | 211,538 | $139.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| TRAWTraws Pharma, Inc. | COM NEW | 678,142 | $124.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DERMJourney Medical Corp | COM | 251,436 | $117.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VSTMVerastem, Inc. | COM NEW | 213,865 | $113.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 58,803 | $111.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| STIMNeuronetics, Inc. | COM | 701,182 | $101.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| LYELLyell Immunopharma, Inc. | COM NEW | 41,081 | $82.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PEPGPepGen Inc. | COM | 447,165 | $79.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 102,211 | $75.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 674,662 | $74.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 18,113 | $71.9 萬 | 0.1% | +18,113 | 新進 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 35,119 | $70.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PMNProMIS Neurosciences Inc. | COM SHS | 55,000 | $69.8 萬 | 0.1% | +55,000 | 新進 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 4,214 | $68.9 萬 | 0.1% | −5,123−54.9% | 減碼 | 歷史 |
| HELPHelus Pharma Inc. | COM NEW | 132,153 | $63.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 28,099 | $62.5 萬 | 0.1% | +28,099 | 新進 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 85,285 | $61.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| EQEquillium, Inc. | COM | 303,555 | $60.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PASGPassage BIO, Inc. | COM | 68,124 | $53.5 萬 | 0.1% | +68,124 | 新進 | 歷史 |
| GUTSFractyl Health, Inc. | COM | 1,100,000 | $50.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PALIPalisade Bio, Inc. | COM | 274,978 | $48.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IMTXImmatics N.V. | SHS | 48,569 | $47.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 9,717 | $31.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| SGMOQSangamo Therapeutics, Inc | COM | 1,218,671 | $30.1 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM | 519,077 | $29.7 萬 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（30 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $1.02 億 | – |
| TERNTerns Pharmaceuticals, Inc. | COM | $6,326 萬 | – |
| CYTKCytokinetics Inc | COM NEW | $3,628 萬 | $2,692 萬 |
| Invesco QQQ Trust Series I46090E103 | ETF | $5,772 萬 | – |
| iShares Russell 2000 ETF464287655 | ETF | $4,960 萬 | – |
| ABVXAbivax S.A. | SPONSORED ADS | – | $3,266 萬 |
| BMYBristol Myers Squibb Co | Stock | $3,033 萬 | – |
| NVONovo Nordisk A S | ADR | – | $1,470 萬 |
| ANIPAni Pharmaceuticals Inc | COM | – | $1,154 萬 |
| CAPRCapricor Therapeutics, Inc. | COM NEW | – | $1,064 萬 |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | $512.4 萬 | $512.4 萬 |
| EYPTEyePoint, Inc. | COM NEW | $477.4 萬 | $477.4 萬 |
| RVMDRevolution Medicines, Inc. | COM | $923.9 萬 | – |
| IONSIonis Pharmaceuticals Inc | COM | – | $841.8 萬 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | $236.6 萬 | $599.4 萬 |
| OLMAOlema Pharmaceuticals, Inc. | COM | – | $819.8 萬 |
| ALMSAlumis Inc. | COM | – | $582.9 萬 |
| Uniqure NVN90064901 | CALL | – | $580.4 萬 |
| BBIOBridgeBio Pharma, Inc. | COM | – | $434.4 萬 |
| KYMRKymera Therapeutics, Inc. | COM | $419.8 萬 | – |
| KODKodiak Sciences Inc. | COM | – | $381.2 萬 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | $361.6 萬 | – |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | $360.5 萬 | – |
| ELVNEnliven Therapeutics, Inc. | COM | $328.1 萬 | – |
| VERAVera Therapeutics, Inc. | CL A | – | $288.4 萬 |
| REPLReplimune Group, Inc. | COM | $229.5 萬 | – |
| TENXTenax Therapeutics, Inc. | COM NEW | – | $182.8 萬 |
| PEPGPepGen Inc. | COM | – | $53.1 萬 |
| MAZEMaze Therapeutics, Inc. | COM | $43.0 萬 | – |
| CNTBConnect Biopharma Holdings Ltd | SHS | – | $37.9 萬 |
2025 年第 4 季之後清倉（24 檔）
2025 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 4 季股數 | 2025 年第 4 季市值 | 2025 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| CDTXCidara Therapeutics, Inc. | COM NEW | 273,243 | $6,036 萬 | 7.8% | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 665,271 | $2,253 萬 | 2.9% | 歷史 |
| AMGNAmgen Inc | Stock | 45,000 | $1,473 萬 | 1.9% | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 3,172,616 | $1,352 萬 | 1.7% | 歷史 |
| CELCCelcuity Inc. | COM | 105,545 | $1,053 萬 | 1.4% | 歷史 |
| PTCTPTC Therapeutics, Inc. | COM | 118,657 | $901.3 萬 | 1.2% | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 958,704 | $865.7 萬 | 1.1% | 歷史 |
| CGONCG Oncology, Inc. | COM | 199,473 | $828.2 萬 | 1.1% | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 54,062 | $766.8 萬 | 1.0% | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 200,000 | $725.8 萬 | 0.9% | 歷史 |
| CORTCorcept Therapeutics Inc | COM | 185,593 | $645.9 萬 | 0.8% | 歷史 |
| ADMAAdma Biologics, Inc. | COM | 234,854 | $428.4 萬 | 0.6% | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 14,814 | $365.2 萬 | 0.5% | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 117,903 | $351.5 萬 | 0.5% | 歷史 |
| AGIOAgios Pharmaceuticals, Inc. | COM | 115,489 | $314.4 萬 | 0.4% | 歷史 |
| ERASErasca, Inc. | COM | 735,396 | $273.6 萬 | 0.4% | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 71,747 | $180.2 萬 | 0.2% | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 45,830 | $160.8 萬 | 0.2% | 歷史 |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 57,388 | $133.9 萬 | 0.2% | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 31,106 | $56.5 萬 | 0.1% | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 4,824 | $33.6 萬 | <0.1% | 歷史 |
| LYRALyra Therapeutics, Inc. | COM NEW | 21,161 | $6.52 萬 | <0.1% | 歷史 |
| SYBXSynlogic, Inc. | COM NEW | 19,966 | $2.24 萬 | <0.1% | 歷史 |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 17,736 | $1.79 萬 | <0.1% | 歷史 |